FdaApplication
NDA 020220
Identifiers
- fda_app_no: NDA020220
Properties
| Property | Value |
|---|---|
| applicant_name | BAYER HEALTHCARE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1995-05-10 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ULTRAVIST 150 | IOPROMIDE | 31.2% | INJECTABLE;INJECTION |
| ULTRAVIST 240 | IOPROMIDE | 49.9% | INJECTABLE;INJECTION |
| ULTRAVIST 300 | IOPROMIDE | 62.3% | INJECTABLE;INJECTION |
| ULTRAVIST 300 IN PLASTIC CONTAINER | IOPROMIDE | 62.3% | INJECTABLE;INJECTION |
| ULTRAVIST 370 | IOPROMIDE | 76.9% | INJECTABLE;INJECTION |
5 products